Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Insomnia
ADR ID BADD_A02362
ADR Hierarchy
17      Nervous system disorders
17.15      Sleep disturbances (incl subtypes)
17.15.03      Disturbances in initiating and maintaining sleep
17.15.03.002      Insomnia
19      Psychiatric disorders
19.02      Sleep disorders and disturbances
19.02.01      Disturbances in initiating and maintaining sleep
19.02.01.002      Insomnia
Description A disorder characterized by difficulty in falling asleep and/or remaining asleep. [CTCAE] Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition. [MeSH]
MedDRA Code 10022437
MeSH ID D007319
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Difficulty sleeping | Insomnia | Insomnia (non-organic) | Insomnia exacerbated | Insomnia NEC | Insomnia NOS | Insomnia related to another mental condition | Other insomnia | Persistent disorder of initiating or maintaining sleep | Primary insomnia | Sleep decreased | Sleep difficult | Sleep loss | Sleeplessness | Transient disorder of initiating or maintaining sleep | Chronic insomnia | Dysphylaxia | Transient insomnia | Agrypnia | Insomnia disorder | Short term insomnia | Secondary insomnia | Sleep Initiation and Maintenance Disorders | Disorders of Initiating and Maintaining Sleep | DIMS (Disorders of Initiating and Maintaining Sleep) | Early Awakening | Awakening, Early | Nonorganic Insomnia | Insomnia, Nonorganic | Primary Insomnia | Insomnia, Primary | Transient Insomnia | Insomnia, Transient | Rebound Insomnia | Insomnia, Rebound | Secondary Insomnia | Insomnia, Secondary | Sleep Initiation Dysfunction | Dysfunction, Sleep Initiation | Dysfunctions, Sleep Initiation | Sleep Initiation Dysfunctions | Insomnia Disorder | Insomnia Disorders | Insomnias | Chronic Insomnia | Insomnia, Chronic | Psychophysiological Insomnia | Insomnia, Psychophysiological
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01325Lovastatin--
BADD_D01326Loxapine--
BADD_D01327Loxapine succinate--
BADD_D01330Lurasidone0.006952%
BADD_D01331Lurasidone hydrochloride--
BADD_D01350Maprotiline--
BADD_D01351Maprotiline hydrochloride--
BADD_D01352Maraviroc--
BADD_D01354Mebeverine--
BADD_D01363Meclofenamate sodium--
BADD_D01365Medroxyprogesterone--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01368Mefenamic acid0.006543%
BADD_D01369Mefloquine--
BADD_D01370Mefloquine hydrochloride--
BADD_D01371Megestrol--
BADD_D01372Megestrol acetate--
BADD_D01373Melatonin0.000976%
BADD_D01374Meloxicam0.000040%
BADD_D01375Meloxicam sodium--
BADD_D01376Melphalan0.000392%
BADD_D01378Memantine--
BADD_D01379Memantine hydrochloride--
BADD_D01381Mepact--
BADD_D01382Mepenzolate--
BADD_D01383Mepenzolate bromide--
BADD_D01384Meperidine--
BADD_D01386Mephenytoin--
BADD_D01391Mercaptoethanesulfonic acid--
BADD_D01393Meropenem--
The 20th Page    First    Pre   20 21 22 23 24    Next   Last    Total 39 Pages
ADReCS-Target
ADR Term Drug Name Target